s6y
Company name or ticker
Search
McManigle Mark Drew
3
Anthera Pharmaceuticals Inc: Initial statement of beneficial ownership of securities
Filed
Wednesday, September 12, 2018
Period
Sep 11, 2018
Accession number
0001214659-18-006012
Documents
PRIMARY DOCUMENT
3
On sec.gov
Filing index
All files
Complete submission text
SGML header